News and Announcements
Alcidion Annouces Release of Miya Clinic
- Published April 20, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Alcidion Group Limited (ASX: ALC) has officially launched the Miya Clinic, following the successful deployment of the technology across Tasmania’s Northern Integrated Care Service.
KEY TAKEAWAYS:
- Tasmania’s Department of Health & Human Services rolls out Miya Clinic.
- Provides a unified Electronic Medical Records for Outpatients Clinics.
The system provides an integrated solution for Outpatient Clinics and is interfaced with Pathology and Radiology Systems (RIS/PACS), Administration System (PAS) and the Outpatient Booking Sydney with integration into the Emergency Department Information Systems (TrakED) scheduled for later this calendar year. Additionally, the solution utilises Alcidion’s “Smartform” technology, that enables clinically coded data to be captured and recorded in the patient’s Electronic Health Record.
Ray Blight commented “This is a further demonstration of the augmentation of the Miya architecture to address specific challenges faced by healthcare. We are delighted to officially launch Miya Clinic today, following its deployment at NICS earlier this year.”
“NICS is delighted to be working with Alcidion on an opportunity to deliver a very much anticipated and ground breaking system that, for the very first time, will provide a holistic view of all the patient information at a centralised modal”, said Jan Coull, eHealth Project manager for NICS.
Alcidion group Limited (ASX:ALC) is a publicly listed, innovative health informatics company that specialises in clinical products that improve productivity, safety and efficiency. Alcidion’s solutions target key problems for Emergency Rooms, Inpatient Services and Outpatient Departments and are built upon a next generation health informatics platform.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
